We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FENG:NYSEPhoenix New Media Limited Analysis

Data as of 2026-06-07 - not real-time

$1.61

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Phoenix New Media (FENG) is trading at $1.61, well below its 20‑day ($1.68), 50‑day ($1.73) and 200‑day ($2.03) moving averages, signaling a bearish technical backdrop. The 14‑day RSI of 34.4 and a bearish MACD histogram suggest the stock is oversold and may be primed for a short‑term bounce, especially as volume has been rising. Valuation metrics are strikingly low, with a trailing P/E of 10.7 versus the industry average of 17.0, a P/B of 0.11 and a price‑to‑sales of 0.02, indicating the market is pricing the ADR at a deep discount. Despite these pressures, the company reported a 21.6% YoY revenue increase in Q1 2026, gross margin improvement to 53.5% and an 83% surge in paid‑services revenue, while operating losses narrowed by 22%.
The balance sheet is exceptionally strong, holding $951 million in cash against a market cap of just $19 million, and a modest debt load of $40 million, giving it a sizable liquidity cushion. However, operating cash flow and free cash flow remain flat at zero and profitability is thin (profit margin 1.66%, ROE 1.1%). The stock’s high 30‑day volatility (≈28.6%) and thin trading volumes raise liquidity concerns, and its exposure to China’s internet‑content regulatory environment adds a layer of geopolitical risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering at the $1.60 support level
  • Oversold RSI and increasing volume
  • Bearish MACD trend remains unresolved

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong Q1 revenue and margin expansion
  • Substantial cash reserves relative to market cap
  • Deep valuation discounts versus peers

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential for sustained cash‑driven turnaround
  • Undervalued multiples offering upside if earnings stabilize
  • Risks tied to Chinese regulatory environment remain manageable with strong liquidity

Key Metrics & Analysis

Financial Health

Revenue Growth21.60%
Profit Margin1.66%
P/E Ratio10.7
ROE1.13%
ROA-1.01%
Debt/Equity3.67
P/B Ratio0.1
Industry P/E17.0

Technical Analysis

TrendBearish
RSI34.4
Support$1.60
Resistance$1.81
MA 20$1.68
MA 50$1.73
MA 200$2.03
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

GradeUndervalued
TypeBlend

Risk Assessment

Beta0.13
Volatility28.65%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.